← Archive
August 7, 2026Health & Welfare

The Daily Brief for Benefits Professionals

BenefitsWire

Health & Welfare Plans

August 7, 2026

— § —

6 items · ~2 min read

Top of the Brief

GLP-1 medications in the United States: The status of coverage, utilization management, and cost in a rapidly evolving market

“Glucagon-like peptide-1 (GLP-1) medications have become a dominant driver of drug spending, with total expenditures in the United States rising to $71.7 billion in 2023, up from $13.7 billion five years earlier. More recent data show that GLP-1s are now the largest and fastest-growing drug category, driven by expanding indications and sustained demand for obesity treatment. As these medications reshape drug spending and clinical practice, payers face mounting pressure to make coverage, utilization management, and contracting decisions—but in this rapidly shifting reimbursement landscape, there is a lack of long-term data available to inform strategic choices.”

In this issue

Health & Welfare Plans (1)  ·  Litigation (3)  ·  General Benefits (2)

Health & Welfare Plans

1 item
GLP-1 medications in the United States: The status of coverage, utilization management, and cost in a rapidly evolving market

“Glucagon-like peptide-1 (GLP-1) medications have become a dominant driver of drug spending, with total expenditures in the United States rising to $71.7 billion in 2023, up from $13.7 billion five years earlier. More recent data show that GLP-1s are now the largest and fastest-growing drug category, driven by expanding indications and sustained demand for obesity treatment. As these medications reshape drug spending and clinical practice, payers face mounting pressure to make coverage, utilization management, and contracting decisions—but in this rapidly shifting reimbursement landscape, there is a lack of long-term data available to inform strategic choices.” MORE >>

Source: Milliman

Litigation

3 items
Smoke Signals: Tobacco Cessation Program Litigation Update

“There are now more than 75 tobacco surcharge class actions pending in federal courts across the nation.” MORE >>

Source: Boutwell Fay

Sixth Circuit Affirms Denial of Preliminary Injunction, Holding That Termination of Disability and Life-Insurance Benefits Does Not Constitute Irreparable Harm

“The court held that the harm Plaintiff alleged, termination of his employment and employment benefits, is quintessentially reparable by money damages. Salaries, short-and long-term disability benefits, life-insurance payments, and retirement benefits are all denominated in terms of money, and denied or withdrawn health-insurance coverage is ultimately monetary in nature and generally remediable with damages.” MORE >>

Source: Roberts Disability Law

Employer Health Plan Design Under Fire: How “Financial Dominance” ERISA Claims Are Expanding in 2026

“Employer-sponsored group health plans are facing a growing wave of ERISA class action lawsuits, and the claims are getting bolder, including claims of “financial dominance”. ... These new cases make clear that the plaintiffs’ bar continues to view financial dominance claims as a growing area of opportunity, and employers need to pay attention.” MORE >>

Source: Thompson Hine (ERISA Litigation & Compliance)

General Benefits

2 items
Employee Benefits and Executive Compensation — Preparing for 2027 — Trump Accounts

“In this episode of Employee Benefits and Executive Compensation — Preparing for 2027, Jim Earle and Jeff Banish, attorneys in Troutman Pepper Locke’s Employee Benefits + Executive Compensation practice, break down Trump accounts, a new type of individual retirement account established under the One Big Beautiful Bill Act designed to build long-term wealth for children. Jim and Jeff walk through who qualifies as an eligible beneficiary, how accounts are established, key rules governing the growth period, including contribution limits and permitted investments, and the federally funded $1,000 pilot program contribution for children born between 2025 and 2028.” MORE >>

Source: Troutman Pepper Locke

10 AnMed facilities remain closed a week after cyberattack

“AnMed, which consists of the 461-bed AnMed Medical Center in Anderson, South Carolina and more than 60 physician practices across South Carolina and Georgia, has kept its urgent care and emergency services locations open throughout the incident. Clinicians still have the ability to access medical records and prescribe medications on a temporarily limited basis, according to an FAQ page.” MORE >>

Source: Healthcare Dive

Also of Note

BenefitsWire · A digest for ERISA attorneys, third-party administrators, actuaries, recordkeepers, and benefits consultants.
An informational digest, not legal advice.
BDK2, LLC, 2503D N Harrison St PMB 2091, Arlington, VA 22207-1640

Get this in your inbox every morning.

Subscribe free